Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting133%
active_not_recruiting133%
completed133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

NCT05335317
active_not_recruitingnot_applicable

Pelvic Organs Prolapse Treatment Using Neodymium Laser

NCT05000957
completednot_applicable

Vulvovaginal Atrophy Correction Using Neodymium Laser

NCT04735549

Clinical Trials (3)

Showing 3 of 3 trials
NCT05335317Not Applicable

Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

Recruiting
NCT05000957Not Applicable

Pelvic Organs Prolapse Treatment Using Neodymium Laser

Active Not Recruiting
NCT04735549Not Applicable

Vulvovaginal Atrophy Correction Using Neodymium Laser

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3